Skip to main content

Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab

Publication ,  Journal Article
Aguirre, FV; Simoons, ML; Ferguson, JJ; Fitzpatrick, SE; Anderson, KM; Kern, MJ; Tcheng, JE
Published in: CIRCULATION
October 21, 1997

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 21, 1997

Volume

96

Issue

8

Start / End Page

898 / 898

Publisher

AMER HEART ASSOC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Aguirre, F. V., Simoons, M. L., Ferguson, J. J., Fitzpatrick, S. E., Anderson, K. M., Kern, M. J., & Tcheng, J. E. (1997). Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab. CIRCULATION, 96(8), 898–898.
Aguirre, F. V., M. L. Simoons, J. J. Ferguson, S. E. Fitzpatrick, K. M. Anderson, M. J. Kern, and J. E. Tcheng. “Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab.” CIRCULATION 96, no. 8 (October 21, 1997): 898–898.
Aguirre FV, Simoons ML, Ferguson JJ, Fitzpatrick SE, Anderson KM, Kern MJ, et al. Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab. CIRCULATION. 1997 Oct 21;96(8):898–898.
Aguirre FV, Simoons ML, Ferguson JJ, Fitzpatrick SE, Anderson KM, Kern MJ, Tcheng JE. Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab. CIRCULATION. AMER HEART ASSOC; 1997 Oct 21;96(8):898–898.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 21, 1997

Volume

96

Issue

8

Start / End Page

898 / 898

Publisher

AMER HEART ASSOC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology